Member Info for R00st3R

Replace the *** with **********

https://www.**********.co.uk/media/6187c293cfcda300170aa25f/?context=/listings/LON/ONC

This interview was conducted on 07.11.21 but still a shorter follow up to the FY21 report from last week. Worth listening into for anyone that has doubt.

It might take until next trading update (i estimate around end of Jan/Feb for half year results) for the share price to have its next bigger breakthrough.

*bn dollar company

I wouldn't want to make too many assumptions here either but I honestly don't see the value for Oncimmune to agree to a takeover. Of course they would have access to a larger set or financial and network resources but primarily it would be a a juicy payoff for all equity holders.
IThe company currently is at the beginning of its journey on a 'blank canvas' with little to no direct competitors in the immediate vicinity and they have a chance to build a true services business that transacts with all Pharma rather than integrate into a narrower network. No doubt will there be interest an offerings on the table soon if not already. But if this is truly a be dollar company in the making, the chance to be acquire will come around more than once. So why seel so early when you can ride the wave of expansion further and then sell at a much higher value.

Agreed and amen. The slowdown in commercial activity was felt across alot of other companies in this space and beyond over the summer. You got to let these guys crack on. HODL and keep buying in. I can only imagine that this coming year will be made of greatness.

I may have missed the point that the big man is stepping down from Media Interviews. Is that actually the case? Does anyone know why?

I think @lightweight84, you are absolutely right to question the cash to debt ratio. I think this was one of the reasons that when the ECLS study was first published 2 years ago the share price dropped massively from 1.15 all the way down to 0.5 if i am not wrong. The ECLS publication was huge news but the company just turned round 175k in revenue and had just received a fresh round of funding (credit facility) bringing their debt to 8mio at the time. Investors were very cautious for this exact reason: Will they burn through all their cash and sink like a lead balloon! But i think ONC did a great job in investing the money where it needed to be invested and the seeds sown are starting to spring and expand. I think ONC is in a great position with alot of commercial momentum that will start accelerating (exponentially i hope) . Also having restructured the board, expanded their lab capacity in Dortmund and selling their overheads in the US, they are absolutely conscious of running a Lean Mean Machine whilst continuing to hire quality professionals into the business. But i am confident that these investments are going to pay off with the expected growth in demand. If they hit the 10mio revenue and the share price stands below 2GBP i will tug my tail between my legs, sell my shares and stare at a wall for a while.

I don't have a penny left. already all in. but the session was extremely bullish especially in the IMMUNOinsights business... buckle up everyone, we still have a ways to go but i can already smell the GOLD

My only concern is that currently 90% of all contract conversion is coming from the US. Sales team projected to grow from 32 to 76 by end of FY 23. Why is the US on fire like that. Is the rest of the world just hard to do business with? would like to see this number more equally spread across the globe especially since this is a company with HQ in UK and facilities in Germany...

THE NIGHT IS DARKEST BEFORE DAWN

Anyone who has read the financial statement should be extremely excited about the coming 12 months where they 3 years strategy will have been implemented with such a strong foundation for exponential future growth. I understand when there is concern based on share price moving the wrong way. That however is purely due to 1.7m invoice unpaid as a result of IFRS-15 reporting requirements not being met. Otherwise the already fantastic 3.8m could have turned into a phenomenal year. This will have been ironed out very quickly.
Look at the strategic partnerships that have been developed and nurtured to allow for expansion in South America, north America, UK, Germany, Spain, China and more. The NHS alone is still just piloting EarlyCDT Lung in a couple of facilities and it is being evaluated by commissioning groups. We are at the very beginning of potentially tremendous revenue coming from this engagement alone in the coming months/years.
To get Oncimmune off the ground is a bone crunching effort and i salute everyone involved at Oncimmune to get to this amazing stage.
My sincere ask is that we remain positive and have believe that this company that until today has delivered will continue to deliver. I am disappointed that the share price dropped and it is tiring to see even when the company is clearly undervalued. But more regular news on closed deals, new partnerships and territories as well as progress on current evaluations would help us all just like a good bottle of water for a marathon runner (that is me sitting at my desk holding my breath)...
This is actually a really good report!

That might very well be the case. We will certainly get more info on this on 2nd Nov.
"...[ONC] will be announcing its full year results for the year ended 31 May 2021 on Tuesday, 2 November 2021."

On the funding side of things, it really is a matter of the government shifting money from A to B with some of it partially coming from the increase in NI contributions.

The Financial year of the NHS is April - March so wonder when funds effectively become available and when contracts can be signed

Wise words. There are many truth when you bring it back to basics. This might just be a herd mentality thing. When interest is shown and hype created, they hop on the bandwagon blindly. Let's hope thats the case. Word of ONC needs to get out there. This gem shouldn't remain in the shadows forever.

I cannot seem to find the exact date but it is going to be published sometime around Nov 4th if i am not mistaken.
I don't think that any drops are related to a missed appointment but could be that the lack of information surfacing through the net is giving some impatient investors the jitters. It is earnings season across many other industries too and i can imagine people wanting to sell a largely static share (ONC) and temporarily capitulate on other stocks that are promising much higher returns short term (look at energy stocks, aviation, technology etc.).
Just my thoughts

Thanks @Trek , last comment was posted before i saw your response. So you say it is effectively about keeping the ball rolling? Trades don't seem to have a big impact anyway...

I bought 193 shares and it shows as expected as a buy. What now? I am puzzled by all other trades. Basically i am puzzled by any SELL motion. Lets just say i want to see this slow burner take off into the right direction. Since june there has effectively been no real movement. I understand that this is long term and that i need to invest what i can afford to lose in individual stocks. I also know that this is the year of 'material revenue' for ONC. This is where all the hard ground work that was done to set up partnerships for global expansion should start coming to fruition. Maybe i ought to shut up and sit tight, best not to dig up truffles from the ground when they ain't ripe. But somehow i need to get to grips with this AIM market and the weird disproportionate price movement. Anyhow. Enough spam from me today. Unfortunately i don't drop gold dust with everything I say like @TrekMadone....i am just in it for the ride cowboys.

@AgentB it is also interesting to me that you post reflects a price of 180 whereby the posts below including mine show 170. Not saying that this is connected but just adds to my confusion...

I scraped a few pounds together to put in here. Let us see in next 10 min what the deal is

Can anyone here explain why there are 20 odd SELL orders for ONC just a couple of weeks shy of what potentially should be a decent report? There are mostly automated trades and many in same volume. I am just confused because i don't understand what the levers are or how these MMs work.

My shares have also all tanked. But i bit the bullet on one of the shares that i held and sold in anticipation that Oncimmune's share price drop would be a huge opportunity to get in ahead of next months annual results and forecast for the year ahead. The SP has no other direction than to go up from here. It must go up.

Alright all, i am pumping in another 2k to help the struggling SP a little. Let us hope it does not drop back into the 150s as a result. I am hopelessly in love with this abusive stock.... at these prices you would hope that investors start getting the tickles and jump on too...